The role of anergy, an acquired state of T cell functional unresponsiveness, in natural peripheral tolerance remains unclear. In this study, we found that anergy was selectively induced in fetal antigen-specific maternal CD4 + T cells during pregnancy. A naturally occurring subpopulation of anergic polyclonal CD4 + T cells, enriched for self antigen-specific T cell antigen receptors, was also present in healthy hosts. Neuropilin-1 expression in anergic conventional CD4 + T cells was associated with hypomethylation of genes related to thymic regulatory T cells (T reg cells), and this correlated with their ability to differentiate into Foxp3 + T reg cells that suppressed immunopathology. Thus, our data suggest that not only is anergy induction important in preventing autoimmunity but also it generates the precursors for peripheral T reg cell differentiation.
Thymocytes that bind self antigen with high affinity are either deleted or selected to become suppressive Foxp3 + regulatory T cells (T reg cells) 1 . Nevertheless, not every self antigen is expressed in the thymus. Consequently, some mature self-reactive CD4 + T cells emigrate to the periphery, where they can recognize complexes of self peptide and major histocompatibility complex (MHC) class II (self peptide-MHC class II). This necessitates peripheral tolerance mechanisms to prevent the development of autoimmune disease 2 .
Anergy is postulated to be one such peripheral tolerance mechanism whereby CD4 + T cells lose the ability to produce autocrine growth factor and proliferate in response to antigen 2, 3 . Multiple biochemical signaling defects have been ascribed to this inactivated state, including the upregulation of genes encoding counter-regulatory products, such as Dgka, Rap1, Cblb, Itch, Rnf128 and Dtx1 (refs. 2,3) . In vivo, anergy is induced by repeated interactions with peptide-MHC class II complexes in the absence of infection or adjuvant but is antagonized by signaling via the kinase mTOR pathway [4] [5] [6] [7] . For CD4 + T cells with transgenic expression of T cell antigen receptors (TCRs), chronic recognition of self peptide-MHC class II in 'normal' (lymphocyte-replete) mice leads to anergy induction in association with the upregulation of the expression of two surface markers: CD73 (encoded by Nt5e) and FR4 (encoded by Izumo1r) 8, 9 . In contrast to such adoptive transfer in 'normal' (lymphocyte-replete) hosts, the adoptive transfer of self-reactive CD4 + T cells into lymphopenic mice lacking Foxp3 + T reg cells fails to elicit the induction of anergy and instead leads to differentiation into effector-memory T cells (T eff-mem cells) and severe immunopathology [9] [10] [11] .
T reg cells are also required for the maintenance of peripheral immunohomeostasis to prevent immunopathology throughout the lifespan of an organism [12] [13] [14] [15] [16] . Most Foxp3 + T reg cells originate in the thymus (tT reg cells) and express neuropilin-1 (Nrp1), but some conventional CD4 + T cells also differentiate in the periphery (pT reg cells) and seem to remain negative for Nrp1 expression [17] [18] [19] [20] . Several studies have indicated that expression of Foxp3 alone is not sufficient to maintain a stable T reg cell lineage. tT reg cells have a defined epigenetic signature (the tT reg cell-like epigenome (tT reg -me)) that consists of hypomethylated CpG motifs at four T reg cell-related genes: Tnfrsf18 (which encodes the immunomodulatory receptor GITR), Ctla4 (which encodes the immunomodulatory receptor CTLA-4 (CD152)), Ikzf4 (which encodes the transcription factor Eos), and Foxp3 (which encodes the transcription factor Foxp3), at its conserved non-coding DNA sequence CNS2 (refs. 20,21) . Expression of Foxp3 protein and development of the tT reg -me epigenetic signature are independent and complementary events in tT reg cell differentiation. Demethylation of select T reg cell signature genes is associated with their constitutive expression, whereas binding of Foxp3 to DNA and transactivation of other signature genes occur only during T reg cell activation [21] [22] [23] [24] . Notably, the loss of Foxp3 expression can occur; this leads to the trans-differentiation of T reg cells into T eff-mem cells capable of causing autoimmunity 25 .
Despite such great potential for CD4 + T cell anergy and T reg cell suppression to act in concert to establish tolerance to peripherally expressed self antigens, the investigation of anergy within a diverse auto-reactive polyclonal repertoire has been difficult, in part due to (g) Flow cytometry analyzing the staining of Nrp1 and Ki67 for 2W1S-I-A b tetramer-binding anergic and T eff-mem cells from mice as in a.
(h) Frequency of Ki67 + 2W1S-I-A b tetramerbinding anergic and T eff-mem cells in mice as in b. (i) Frequency of tetramer-enriched cells positive for intracellular staining of IL-2 in pregnant female mice of mice as in a (wildtype x Act2W) on day 18 of gestation, 2 h after injection 100 µg of 2W1S peptide. Each symbol (b,e,f,h,i) represents an individual mouse; small horizontal lines indicate the mean (± s.e.m.). *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (one-way analysis of variance (ANOVA) (b,e,f,h) or unpaired one-tailed Student's t-test (i)). Data are representative of three to four independent experiments with n = 3-6 mice in each.
the lack of identifying markers. We now report a previously unknown subset of naturally occurring Foxp3 − CD44 hi CD73 hi FR4 hi polyclonal CD4 + T cells that were functionally anergic in healthy hosts. This anergic subset showed enrichment for self antigen-specific TCRs and was also induced in response to recognition of fetal antigens during pregnancy. Notably, Nrp1 + anergic conventional CD4 + T cells displayed the tT reg -me signature and 'preferentially' gave rise to functional Foxp3 + Nrp1 + pT reg cells in vivo. Thus, the induction of anergy not only serves to diminish the proliferative responsiveness of potentially dangerous self-reactive CD4 + T cells but also generates progenitor cells for pT reg cell differentiation.
RESULTS
Development of anergy by fetal antigen-reactive CD4 + T cells KRN CD4 + T cells, which have transgenic expression of a TCR specific for self glucose-6-phosphate isomerase (GPI) presented by the MHC class II molecule I-A g7 , undergo abortive clonal expansion, upregulate their expression of CD73 and FR4 and develop anergy when transferred into healthy hosts of the H-2 g7 strain 9 . Mice of the NOD (non-obese diabetic) strain also accumulated unresponsive Foxp3 − CD44 hi CD73 hi FR4 hi insulin-specific polyclonal CD4 + T cells in the pancreatic lymph nodes before the onset of frank diabetes 26 (Supplementary Fig. 1) . These results suggested that anergy might serve as a natural checkpoint for peripheral self-tolerance and as a barrier to the development of autoimmune disease.
We therefore aimed to study anergy in a more physiological polyclonal setting in which the specificity of the self antigen was known and a timeline for tolerance induction could be established. We made use of a model of fetal antigen-specific tolerance wherein male C57BL/6 (B6) Act2W breeder mice, a strain engineered to transgenically and ubiquitously express the antigenic peptide 2W1S (a variant of a peptide consisting of amino acids 55-68 of the α-chain of I-E d ), are crossed with non-transgenic (wild-type) syngeneic B6 female mice 27 . We assessed, in the mothers, the development of tolerance in the 2W1S-I-A b -specific polyclonal CD4 + T cell compartment, as defined through the use of 2W1S-I-A b tetramers 28 . A small population of 2W1S-specific CD4 + T cells (~400) was present in virgin (wild-type) female mice, and this number did not change by day 18 of gestation in pregnant female mice bred to non-transgenic (wild-type) male mice ( Fig. 1a,b ). However, pregnant wild-type hosts crossed with male Act2W mice (which, as noted above, have transgenic expression of 2W1S) a Virgin (WT)
WT × WT WT × Act2W A r t i c l e s demonstrated a small yet significant increase in the abundance of 2W1S-specific Foxp3 − CD44 hi conventional CD4 + T cells that co-expressed CD73 and FR4 relative to that of pregnant wild-type hosts crossed to male wild-type mice ( Fig. 1a-f) , consistent with the hypothesis that they had been made anergic following the recognition of fetus-derived 2W1S. More than 80% of anergic T cells also specifically expressed Nrp1 by day 18 of pregnancy ( Fig. 1g and data not shown). Expression of the proliferation marker Ki67 increased in both the CD73 hi FR4 hi (anergic) fraction and the CD73 lo FR4 lo fraction (called 'T eff-mem cells' here) of CD44 hi 2W1S-specific T cells through day 10 of pregnancy, but at later time points, Ki67 expression decreased specifically in the anergic T cell group (Fig. 1g,h) , indicative of the development of proliferative unresponsiveness. Consistent with proliferative anergy, at day 18 of pregnancy in the wild-type × Act2W cross noted above, a significantly lower proportion of anergic 2W1S-specific CD4 + T cells than T eff-mem cells retained the ability to synthesize interleukin 2 (IL-2) in response to in vivo challenge with 2W1S ( Fig. 1i) . By 14 d postpartum, the anergic 2W1S-I-A b -specific maternal CD4 + T cells demonstrated a sharp decrease in number ( Fig. 1e,f) , which suggested that continuous antigen recognition and/or the pregnant state were (was) required for maintenance of the phenotype or survival of CD4 + T cells made anergic to a fetal antigen. Together these results validated the use of CD73 and FR4 as predictive biomarkers of the induction of anergy in polyclonal CD4 + T cells in vivo.
CD73 and FR4 expression by anergic polyclonal CD4 + T cells
To investigate the general importance of in vivo anergy to peripheral self-tolerance, we focused our attention on conventional CD4 + T cells that expressed the combination of the activation and memory marker CD44, CD73 and FR4 within secondary lymphoid organs. As naive Foxp3 − CD44 lo CD4 + T cells in the lymph nodes and spleen have only low to intermediate expression of CD73 and FR4, these cells were used to set flow cytometry gates, and then npg the Foxp3 − CD44 hi polyclonal CD4 + T cell repertoire was examined for evidence of high co-expression of CD73 and FR4 ( Fig. 2a) .
A population of Foxp3 − CD44 hi CD73 hi FR4 hi polyclonal CD4 + T cells was identified in all healthy mouse strains tested; this population constituted approximately 2-5% of the total peripheral CD4 + T cell compartment ( Fig. 2a,b ). Both the frequency and absolute number of polyclonal anergic-phenotype CD4 + T cells rose with age ( Fig. 2c) . Similar to results reported for mice deficient in the pro-apoptotic protein Bim 29 , mice deficient in the transcriptional regulator Aire (Aire −/− ), which have defective central T cell tolerance, showed a significantly greater number and frequency of anergic-phenotype CD4 + T cells in the lymph nodes and spleen than that of their Aire +/− (control) littermates ( Fig. 2b,d) . Notably, Foxp3 − CD44 hi CD73 hi FR4 hi polyclonal CD4 + T cells produced little IL-2 at either 8 h or 96 h following in vitro stimulation with the combination of monoclonal antibody (mAb) to the invariant signaling protein CD3 and mAb to the coreceptor CD28 ( Fig. 2e) .
The in vitro proliferation of anergic polyclonal T cells in response to 96 h of stimulation with mAb to CD3 and mAb to CD28 (cell divisions, 1.0 ± 0.2 (average ± s.d.) was similarly reduced compared with that of naive CD4 + T cells (cell divisions, 4.0 ± 0.1) (data not shown). For all other cytokines tested, including TNF, IFNγ, IL-17a, IL-10 and IL-21, anergic cells showed little response to in vitro stimulation with the phorbol ester PMA and ionomycin, in contrast to the substantial response of antigen-experienced T eff-mem cells (Fig. 2f,g) . Therefore, the development of a peripheral Foxp3 − CD44 hi CD73 hi FR4 hi anergic CD4 + T cell phenotype was not an infrequent event in healthy mice, was enhanced in the setting of defective central tolerance and was associated with a diminished capacity to produce IL-2 and proliferate. npg A r t i c l e s Anergic cell quiescence despite tonic antigen recognition Consistent with results obtained with the pregnancy model, naturally anergic CD4 + T cells did not seem to be in cell cycle, as indicated by their low expression of Ki67 and low forward scatter ( Fig. 3a and data not shown). Despite such proliferative quiescence, the expression of cell-activation markers (for example, CD69, PD-1 and CTLA-4) typically associated with strong engagement of the TCR was high on anergic T cells (Fig. 3b) . Studies of a Nur77 GFP reporter mouse (with transgenic expression of green fluorescent protein (GFP) from the Nr4a1 locus encoding the nuclear receptor Nur77), used to monitor TCR signal strength in vivo 30 , concluded that the high Nur77 expression found in T reg cells was a consequence of the expression of high-affinity TCRs for self peptide-MHC class II. Using this Nur77 GFP reporter mouse, we found that Nur77 expression in anergic T cells was comparable to that in T reg cells and higher than that in either naive T cells or T eff-mem cells (Fig. 3c) . Expression of the negative regulator of TCR signaling CD5 and Nrp1 on anergic T cells was also similar to that on T reg cells but higher than that on both T eff-mem cells and naive T cells (Fig. 3c) . Consistent with those protein data, a survey of mRNA expression in these T cell subpopulations confirmed a unique gene signature of anergic CD4 + T cells that was different from that of either conventional T eff-mem cells or T reg cells and included expression of the gene encoding the anergyassociated E3 ubiquitin ligase GRAIL (Rnf128) 31 (Fig. 3d) . Thus, anergic T cells in healthy mice showed many signs of persistent recognition of self peptide-MHC class II and engagement of the TCR similar to that of T reg cells, yet they seemed to be non-proliferative.
Reversal of anergy during T cell lymphopenia
Naive GPI-I-A g7 -specific KRN CD4 + T cells cause arthritis when transferred into lymphopenic B6 × B6.g7 F 1 (B6G7F1) mice (which are deficient in the TCR α-chain (Tcra −/− ) and express GPI-I-A g7 ), due to a failure in the induction of anergy in the absence of T reg cells 9, 32 . We also found that KRN CD4 + T cells made anergic in GPI-I-A g7 -expressing wild-type mice inevitably lost their expression of CD73 and FR4 and caused arthritis and wasting disease following their adoptive transfer into lymphopenic Tcra −/− recipients (Supplementary Fig. 2) . Therefore, we investigated whether highly purified GFP − CD44 hi CD73 hi FR4 hi anergic polyclonal CD4 + T cells from Foxp3 DTR mice (which express the receptor for diphtheria toxin (DTR) under control of the endogenous Foxp3 locus) also underwent anergy reversal and caused immunopathology following their adoptive transfer to Tcra −/− lymphopenic hosts (Supplementary Fig. 3) .
Reversal of anergy did occur in lymphopenic mice, as most anergic T cells downregulated their expression of CD73 and FR4 and underwent clonal expansion consistent with a restoration of proliferative responsiveness; however, anergy reversal failed to elicit any evidence of disease by day 21 (Fig. 4a-c) . 20% ± 5% (mean ± s.d.) of the total donor-derived CD4 + T cells developed a T reg cell phenotype when anergic donor T cells were used ( Fig. 4d,e) . In contrast, naive polyclonal CD4 + T cells and polyclonal CD4 + T eff-mem cells failed to give rise to as many T reg cells after adoptive transfer into Tcra −/− hosts (Fig. 4d,e ). This differentiation of anergic conventional CD4 + T cells into T reg cells was not unique to lymphopenic hosts, as the adoptive transfer of purified anergic T cells into wild type B6 hosts also led to Fig. 1d (c) or Fig. 1c (d) ). (e) Frequency (top) and quantification (below) of Foxp3 + T reg cells among total donor CD4 + T cells recovered on day 21 from host mice as in a. (f) Flow cytometry analyzing the expression of CD44 and Foxp3 by donor-derived CD4 + T cells recovered on day 30 from syngeneic lymphoreplete B6 host mice given sorted naive or anergic Foxp3 DTR polyclonal CD4 + T cells (5 × 10 5 ) (numbers adjacent to outlined areas as in Fig. 1c ). the conversion of 9.5% ± 6.3% of the cells into a T reg cell phenotype (Fig. 4f,g) . Therefore, polyclonal anergic CD4 + T cells seemed to be uniquely capable of differentiating into T reg cells.
Deletion of anergy-derived T reg cells causes immunopathology
The resistance of the Tcra −/− hosts to immunopathology following the adoptive transfer of polyclonal anergic CD4 + T cells led us to the hypothesis that newly differentiated T reg cells inhibited the pathogenicity of other non-T reg cells following anergy reversal. To test this hypothesis, we used diphtheria toxin (DT) to selectively ablate any Foxp3-expressing T cells that arose from purified anergic Foxp3 DTR donor T cells during anergy reversal (Supplementary Fig. 4) .
The majority of Tcra −/− mice that received both anergic T cells and DT developed a severe wasting syndrome by day 21 (Fig. 5a) . This weight loss was not simply a result of DT toxicity, as mice that received anergic cells from a Foxp3 GFP mouse and given the same DT regimen showed no sign of disease ( Fig. 5a) . Selective ablation of T reg cells during anergy reversal also led to an increase in the number of T eff-mem cells expressing the transcription factor T-bet compared with the number of such cells in anergic mice treated with PBS instead of DT ( Fig. 5b-d) , consistent with suppression of their clonal proliferation by anergyderived T reg cells in the absence of DT. Additionally, serum obtained from DT-treated recipients of anergic Foxp3 DTR T cells contained autoantibodies reactive to several tissues ( Fig. 5e and Supplementary  Fig. 5) , indicative of the development of systemic autoimmunity. In contrast to recipients of anergic T cells, all lymphopenic mice that received either naive T cells or T eff-mem cells from Foxp3 DTR donors remained healthy at day 21, even in the presence of DT ( Fig. 5 and data not shown). Thus, the anergic Foxp3 − CD44 hi CD73 hi FR4 hi polyclonal CD4 + T cell population in healthy mice naturally included T cells with potentially dangerous TCRs, as well as conventional CD4 + T cells that were able to differentiate into protective T reg cells.
Suppression of autoimmunity by anergy-derived T reg cells
To formally test the suppressive ability of anergy-derived T reg cells, we first reconstituted lymphopenic Tcra −/− B6G7F1 host mice with purified syngeneic polyclonal CD4 + anergic T cells for a period of 21 d, then gave those mice a second adoptive transfer of KRN CD4 + T cells to elicit autoimmune arthritis. Anergic T cells again gave rise to T reg cells (Supplementary Fig. 6a-c) . Consistent with the generation of strong in vivo T reg cell activity, reconstitution with anergyderived T reg cells was associated with suppression of the KRN T cell clonal expansion and protection from severe arthritis ( Fig. 6a,b) .
Reconstitution of Tcra −/− hosts with anergy-derived T reg cells also npg A r t i c l e s led to upregulation of the expression of CD73 and FR4 in the KRN T cells (Fig. 6c) , consistent with their induction of anergy. The use of DT to selectively ablate newly generated T reg cells during anergy reversal increased arthritis (data not shown). In contrast to mice reconstituted with anergic cells, mice reconstituted with T eff-mem cells developed severe arthritis, and this was associated with a greater number of KRN T cells than that of mice reconstituted with anergic cells (Fig. 6a,b) . 33, 34 , we discovered that the transfer of anergic polyclonal T cells together with the naive CD4 + T cell population allowed the differentiation of anergy-derived T reg cells that suppressed the clonal expansion of the naive donor T cell progeny ( Fig. 6d and Supplementary Fig. 6d,e) . Furthermore, the co-transferred anergic T cells protected all host mice against the development of chronic wasting disease, colitis and typhlitis, similar to the co-transfer of true T reg cells (Fig. 6e,f) . In contrast, all Tcra −/− mice that received naive syngeneic CD4 + T cells either alone or in combination with T eff-mem cells lost weight, and half of these mice demonstrated histological evidence of both colitis and typhlitis ( Fig. 6d-f ). Together these results established that anergy-derived T reg cells suppressed CD4 + T cell-mediated immunopathology, on the basis of their ability to block the clonal expansion of autoreactive T cells, promote the induction of T cell anergy and prevent the development of autoimmune arthritis and inflammatory bowel disease.
By exploring a second model of inflammatory bowel disease dependent on the T H 17 and/or T H 1 subset(s) of helper T cells that is induced by the adoptive transfer of naive polyclonal CD4 + T cells into lymphopenic mice
Unique tT reg -me signature of some anergic cells We sought to determine why the anergic CD4 + T cells were predisposed to T reg cell differentiation. The function and stability of tT reg cells is thought to depend on the expression of Foxp3 as well as the induction of a tT reg -me signature 21 . This tT reg -me signature consists of hypomethylated CpG motifs at Tnfrsf18 exon 5, Ctla4 exon 2, Ikzf4 intron 1b and Foxp3 intron 1. Cells that have the tT reg -me signature but lack expression of Foxp3 are proposed to be 'potential T reg cells' 20 .
To determine whether demethylation of tT reg -me signature genes was involved in the differentiation of anergic T cells into T reg cells, we performed bisulfite sequencing of DNA purified from naive T cells, T eff-mem cells, anergic T cells and T reg cells. At Tnfrsf18 exon 5, 17% of DNA clones from anergic T cells underwent demethylation of all four CpG positions in a pattern similar to that of the majority of T reg cells (Fig. 7a) . The remainder of the anergic T cell-cloned Tnfrsf18 alleles were heavily methylated at exon 5, similar to its methylation in naive T cells or T eff-mem cells (Fig. 7a) . For the five CpG positions of Ctla4 exon 2, a total of 50% of the anergic T cell clones demonstrated at least three demethylations, whereas three or more demethylations were never observed in either naive T cells or T eff-mem cells (Fig. 7b) . Naive alone Naive + T eff-mem Naive + anergic Naive + T reg f Figure 6 T reg cells generated from anergic CD4 + polyclonal T cells prevent arthritis and colitis. (a) KRN cells recovered from wild-type and Tcra −/− B6G7F1 control mice given no Foxp3 DTR cells (left two bars), or lymphopenic Tcra −/− B6G7F1 host mice reconstituted for 21 d with 1.5 × 10 6 syngeneic T eff-mem cells, anergic or T reg cells sorted from polyclonal CD4 + T cells pooled from the spleen and lymph nodes (as in Fig. 1a ) of a Foxp3 DTR mouse, followed by transfer of 1 × 10 4 naive KRN CD4 + T cells into the mice and analysis on day 12 after transfer of KRN cells. (b) Clinical arthritis index scores 9 of the mice in a. (c) Flow cytometry analyzing the expression of FR4 and CD73 on KRN T cells recovered on day 33 from mice as in a (numbers in outlined areas, as in Fig. 1d ). In fact, 43% of the anergic cell clones showed a unique partial demethylation pattern not seen in any other naive T cell, T eff-mem cell or T reg cell group (Fig. 7b) . A few anergic T cell clones (14%) were again fully demethylated at Ikzf4 intron 1b, as in T reg cells, with the remainder of the clones having methylation more similar to that in naive T cells or T eff-mem cells (Fig. 7c) . Different from either naive T cells or T eff-mem cells, 14% ± 12% (mean ± s.d.) of anergic clones showed complete demethylation of all twelve CpG positions of Foxp3 intron 1, similar to T reg cells, and this contributed to the finding that a total of 18% of the anergic clones had at least three demethylated CpG motifs (Fig. 7d) . Consistent with peripheral conversion to a stable T reg cell lineage, anergy-derived T reg cells demonstrated the full tT reg -me demethylation signature ( Fig. 7e-h) . We observed only a very low frequency of formerly Foxp3-expressing cells ('ex-Foxp3 cells') in the anergic CD4 + T cell compartment, as measured by Foxp3 promoterdriven fate mapping 35, 36 (Supplementary Fig. 7a-c) . Therefore, this unique anergic T cell gene demethylation signature seemed to reflect a predisposition to differentiate into a stable T reg cell lineage rather than a history of previous commitment to the T reg cell lineage and subsequent loss of Foxp3 expression.
T reg cell progenitors among Nrp1 + anergic cells More than 60% of Foxp3 − CD44 hi CD73 hi FR4 hi anergic polyclonal CD4 + T cells expressed Nrp1 at steady state, and Nrp1 expression increased on fetal antigen-specific anergic T cells as pregnancy progressed (Figs. 1h  and 3c and data not shown). Given the high expression of Nrp1 on tT reg cells and that it promotes T reg cell stability by inhibiting de-differentiation programs [17] [18] [19] , we sought to determine whether its expression on certain anergic T cells could be used to predict a greater capacity to differentiate into the T reg cell lineage. Bisulfite sequencing showed that Nrp1 + anergic T cells had more demethylation of tT reg -me signature genes ( Fig. 8a-d) . Complete demethylation of Foxp3 intron 1 was observed in 4% ± 7% (mean ± s.d.) of Nrp1 + clones, and this contributed to the finding that a total of 27% of the clones had demethylation of at least three CpG motifs ( Fig. 8a-d) . Although the n value of the sample was too low for the detection of small differences between the a   4  3  2  5  1  4  3  2  5  1  4  3  2  5  1  4  3  2 4  3  2  6  5  1  4  3  2  6  5  1  4  3  2  6  5  1  4  3  2  6 npg A r t i c l e s sorted populations, this number of fully demethylated Foxp3 genes in Nrp1 + anergic T cells was not significantly different from that of the bulk population (P = 0.15; unpaired one-tailed t-test). We found that Nrp1 expression on anergic T cells could also be used to predict hypomethlyation of Ctla4 exon 2, as 32% of Nrp1 + clones had demethylation of three or more CpG motifs of Ctla4 exon 2 ( Fig. 8a-d) . In contrast, Nrp1 − anergic clones never demonstrated demethylation of three or more CpG motifs at either Foxp3 or Ctla4 (Fig. 8a-d) . Finally, adoptive transfer of purified Nrp1 + anergic T cells into lymphopenic Tcra −/− mice led to reduced overall T cell clonal expansion after anergy reversal but an increased frequency and number of T reg cells, compared with results obtained by a similar transfer of Nrp1 − cells (Fig. 8e-h) . Together these data suggested that Nrp1 + anergic T cell populations showed enrichment for T reg cell precursors.
DISCUSSION
We have investigated here a naturally occurring subpopulation of Foxp3 − CD44 hi CD73 hi FR4 hi polyclonal CD4 + T cells that demonstrated defective IL-2 production. Their high expression of CD69, PD-1, Nrp1, CTLA-4, CD5, Nur77 and Rnf128 (but low expression of Ki67) suggested that they regularly came in contact with highaffinity self peptide-MHC class II complexes and developed anergy. We note that a published study failed to identify anergic polyclonal CD4 + T cells on the basis of high activation of the gene encoding Nur77 yet poor Ca 2+ mobilization triggered by CD3 (ref. 37 ). Nevertheless, Bim −/− mice with defective thymic clonal deletion of T cells have an increased frequency of CD4 + T cells in the periphery with an anergic Nur77 hi CD73 hi FR4 hi phenotype 29 . Here we associated upregulation of the expression of CD73 and FR4 with the induction of anergy in polyclonal CD4 + T cells through the use of various systems of immunological tolerance and have established the existence of anergy as a natural CD4 + T cell peripheral tolerance mechanism that might be particularly important when central tolerance fails.
The previous failure to identify anergic Nur77 hi CD4 + T cells might have been related to insufficient assay sensitivity or, more likely, indicates that Ca 2+ signaling remains undisturbed in anergic CD4 + T cells. Anergy to fetal antigen was lost postpartum, probably as a consequence of falling levels of peptide-MHC class II complex 38 . Such a requirement for continuous antigen recognition would indicate that at least some signaling pathways downstream of the TCR (perhaps including intracellular Ca 2+ mobilization) remain intact in anergic T cells. Constant antigen recognition is similarly required for the optimal function and stability of T reg cells 39, 40 . Other phenotypic characteristics shared by anergic CD4 + T cells and T reg cells (for example, high expression of PD-1, CTLA-4, CD69, Nrp1 and Nur77) can also be taken as signs of recent and/or ongoing engagement of the TCR. Therefore, we propose that similar to the stability and survival of T reg cells, the stability and survival of a diverse self-reactive TCR repertoire within the anergic CD73 hi FR4 hi T cell compartment is dictated by repeated and chronic antigen encounter.
During normal aging, mice accumulate CD4 + T cells with a 'senescent' PD-1 hi memory phenotype (CD44 hi ) that have defects in cytokine production and proliferation 41 . Similar to those PD-1 hi memory T cells, anergic Foxp3 − CD44 hi CD73 hi FR4 hi CD4 + T cells accumulated in older mice, with increased expression of PD-1, CD69, Bcl6, Cxcr5 and Spp1 (data not shown). Osteopontin (encoded by Spp1) 4 3  2  1  4  3  2  1  4  3  2  5  1  4  3  2  5  1  4  3  2  6  5  1  4  3  2  6  5  1  10  9  8  12  11  7  4  3  2  6  5  1  10  9  8  12  11  7  4  3  2  6 can bind to the transcriptional repressor Bcl-6 and promote the differentiation of CXCR5 + follicular helper T cells and follicular regulatory T cells 42 . Whether anergy is an intermediate in the development of CD4 + T cell senescence remains unknown. Regardless, the upregulation of Bcl-6 expression that occurs during chronic TCR stimulation and anergy induction might be key to the differentiation of follicular helper T cells versus that of Foxp3 + follicular regulatory T cells, once anergy reverses. T reg cells are essential to anergy induction in vivo 9, 10, 43 . T reg cells might also be important for anergy maintenance, given that the adoptive transfer of anergic CD4 + T cells into Tcra −/− hosts led to downregulation of their expression of CD73 and FR4 and their spontaneous clonal expansion. Following reversal of anergy, both KRN T cells (data not shown) and Nrp1 − polyclonal CD4 + T cells took on a T H 1 or T H 17 effector phenotype and caused immunopathology in the absence of T reg cells. More notably, after anergy reversal, the Nrp1 + CD73 hi FR4 hi polyclonal conventional CD4 + T cell subset gave rise to pT reg cells with a tT reg -me epigenetic signature. For the development of tT reg cells, the strength of TCR signaling induces Foxp3 expression, whereas its duration establishes the tT reg -me epigenetic signature 20, 21 . It remains to be determined whether the chronicity of peptide-MHC class II recognition during the course of anergy induction also controls either Nrp1 expression or demethylation of tT reg -me signature genes.
Finally, it remains unclear why anergic KRN CD4 + T cells failed to generate T reg cells after anergy reversal. Other CD4 + T cell lines with transgenic expression of TCRs (TCR-HA, DO11.10 and OT-II) differentiate to CD25 + Foxp3 + T reg cells following treatment of mice with anti-DEC-205-targeted peptide antigen, an activation regimen known to also induce anergy [44] [45] [46] . In such experiments, CD62l int CD 69 hi CD25 + Foxp3 − intermediate cells capable of fully differentiating into CD25 + Foxp3 + T reg cells in response to exogenous IL-2 are also generated. KRN T cells made anergic after 6 d in wild-type B6G7F1 hosts generally did not express either the cytokine receptor CD25 or Foxp3 (data not shown). A polyclonal CD62L int CD69 hi CD25 + Foxp3 − mature CD4 + T cell compartment has also been identified that contains T reg cell precursors 46 . Although the Foxp3 − Nrp1 + CD44 hi CD7 3 hi FR4 hi anergic CD4 + T cells described here did not express CD25 (data not shown), it is conceivable that these two T reg cell progenitor populations are related and that anergy induction and subsequent CD25 expression are key to the peripheral differentiation of stable Foxp3 + T reg cells. Regardless, anergy-derived T reg cells are potent and broadly functional, given their ability to suppress the clonal expansion of dangerous CD4 + T cells, induce them into an anergic state, and block autoantibody production, wasting disease, inflammatory bowel disease and autoimmune arthritis. Given that TCR engagement, Nrp1 expression and the tT reg -me signature all serve to maintain the optimal stability, function and survival of T reg cells 19, 21, 39, 40 , we now speculate that Nrp1 + anergic CD4 + T cells reactive to self peptide-MHC class II bearing hypomethylated tT reg -me loci are ideal progenitors for the peripheral differentiation of stable Foxp3 + pT reg cells.
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